0001209191-20-039193.txt : 20200626
0001209191-20-039193.hdr.sgml : 20200626
20200626211717
ACCESSION NUMBER: 0001209191-20-039193
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200625
FILED AS OF DATE: 20200626
DATE AS OF CHANGE: 20200626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EVANS GARY C
CENTRAL INDEX KEY: 0001191410
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 20995713
MAIL ADDRESS:
STREET 1: 1048 TEXAN TRAIL
CITY: GRAPEVINE
STATE: TX
ZIP: 76051
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-25
0
0001000694
NOVAVAX INC
NVAX
0001191410
EVANS GARY C
C/O NOVAVAX, INC.
21 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
1
0
0
0
Stock Option (Right to buy)
83.54
2020-06-25
4
A
0
6900
0.00
A
2021-06-25
2030-06-25
Common Stock
6900
6900
D
Restricted Stock Units
2020-06-25
4
A
0
3450
0.00
A
Common Stock
3450
3450
D
One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest one (1) year from the June 25, 2020 grant date (the "Grant Date"), subject to continued service on the Company's Board of Directors through the vesting date.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
One hundred percent (100%) of the RSUs subject to this grant under the Plan, will vest one (1) year from the Grant Date, subject to continued service on the Company's Board of Directors through the vesting date.
/s/ John A. Herrmann III, Attorney-in-Fact
2020-06-26